China · Series C startup
2 rounds we have observed, with the 9 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Raised 2 months ago
Follow Nutshell Therapeutics and see its new rounds in your feed. Start following
Funding summaryUpdated 5 Nov 2026
$40Mraised across 2 rounds since 2022, from 2 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Reported by TechStartups
Source recorded
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Missing a round, or an investor who was in one? Tell us.
Nutshell Therapeutics's investors include Decheng Capital, Trustbridge Capital, Tengxun Touzi, Matrix Partners China and Northern Light Venture Capital, and 4 more on record. Decheng Capital led its latest round.
Nutshell Therapeutics has raised $40M across 2 rounds since 2022. One round did not disclose an amount, so the total is a floor.
Nutshell Therapeutics's most recent round was a Series C in Sept 2026, led by Decheng Capital.
Nutshell Therapeutics's largest round on record is $40M (Series A), in Mar 2022.
Nutshell Therapeutics's first round on record, in Mar 2022, was backed by Tengxun Touzi, Matrix Partners China and Northern Light Venture Capital and 2 others.
Nutshell Therapeutics's latest named round is a Series C, in Sept 2026.
Nutshell Therapeutics is based in China.
Decheng Capital led the Series C in 2026.
In the same sector, and raised in the last eighteen months.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
China · 
